Denali Therapeutics Inc. Ratios

Ratios Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Profitability
EBT Margin -28.06%-742.05%21.44%-598.34%-300.54%-43.93%
EBIT Margin -35.90%-799.10%18.69%-607.78%-314.16%-59.51%
EBITDA Margin -28.28%-736.99%21.02%-601.79%-304.60%-41.66%
Operating Margin -35.90%-799.10%18.69%-607.78%-314.16%-59.51%
Net Margin -28.06%-740.74%21.19%-597.15%-300.56%-43.94%
FCF Margin 36.17%-635.34%123.06%-451.88%-242.06%-112.22%
Efficiency
Assets Average 574.35M607.61M1,078.76M1,504.22M1,432.20M1,307.08M1,264.05M
Equity Average 185.82M506.32M470.87M772.71M1,056.41M1,002.36M1,036.69M1,130.32M
Invested Capital -94.15M465.80M546.85M394.89M1,150.53M962.29M1,046.82M1,030.95M1,239.03M
Asset Utilization Ratio 0.220.040.310.030.080.25
Leverage & Solvency
Debt to Equity 0.00
Debt Ratio 0.00
Equity Ratio 0.960.830.710.720.690.710.890.89
Valuation
Enterprise Value -39.85M1,667.44M1,651.12M1,257.51M7,216.96M4,581.39M2,328.11M1,931.19M1,868.68M
Market Capitalization 2,073.67M2,115.42M1,672.86M8,686.66M5,446.80M3,664.33M2,965.70M2,701.01M
Return Ratios
Return on Sales -0.28%-7.41%0.21%-5.97%-3.01%-0.44%
Return on Capital Employed -0.09%-0.38%0.06%-0.26%-0.32%-0.16%-0.42%
Return on Invested Capital -0.45%0.08%-0.28%
Return on Assets -0.06%-0.33%0.07%-0.19%-0.23%-0.11%-0.33%
Return on Equity -0.47%-0.07%-0.42%0.09%-0.28%-0.33%-0.14%-0.37%